Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$760M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$430M |
| 3 |
NVIDIA
NVDA
|
+$287M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$268M |
| 5 |
XYZ
Block Inc
XYZ
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$475M |
| 2 |
Pfizer
PFE
|
+$356M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$325M |
| 4 |
Apple
AAPL
|
+$325M |
| 5 |
Microsoft
MSFT
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17% |
| 2 | Financials | 12.96% |
| 3 | Healthcare | 12.18% |
| 4 | Consumer Discretionary | 8.39% |
| 5 | Industrials | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Icon
ICLR
$12.8B
| $38.1M | 0.02% |
294,693
+97,054
| +49% | +$13.4M |
|
727
Veeva Systems
VEEV
$38.1B
| $38M | 0.02% |
424,958
-370,755
| -47% | -$33.9M |
|
728
Medpace
MEDP
$16.8B
| $37.7M | 0.02% |
712,428
-8,340
| -1% | -$458K |
|
|
CMD
729
DELISTED
Cantel Medical Corporation
CMD
| $37.6M | 0.02% |
505,654
+49,458
| +11% | +$4.08M |
|
730
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.59B
| $37.6M | 0.02% |
843,206
+241,674
| +40% | +$11.1M |
|
731
Tactile Systems Technology
TCMD
$657M
| $37.5M | 0.02% |
822,158
+98,351
| +14% | +$5.67M |
|
732
Liberty Global Class C
LBTYK
$3.41B
| $37.4M | 0.02% |
1,814,466
+321,627
| +22% | +$7.69M |
|
733
Vanguard Total International Stock ETF
VXUS
$162B
| $37.4M | 0.02% |
793,013
+153,625
| +24% | +$7.64M |
|
734
NYLI Hedge Multi-Strategy Tracker ETF
QAI
$1.02B
| $37.3M | 0.02% |
1,298,306
+87,594
| +7% | +$2.62M |
|
735
Copa Holdings
CPA
$5.58B
| $37.2M | 0.02% |
472,618
+32,908
| +7% | +$2.58M |
|
736
iShares Core S&P US Growth ETF
IUSG
$33.8B
| $37.2M | 0.02% |
707,810
+203,941
| +40% | +$11.6M |
|
737
Leidos
LDOS
$17.5B
| $37.2M | 0.02% |
704,983
+9,058
| +1% | +$563K |
|
738
Archer Daniels Midland
ADM
$38.8B
| $37.1M | 0.02% |
906,141
-119,120
| -12% | -$5.55M |
|
739
AGCO
AGCO
$7.06B
| $37.1M | 0.02% |
666,206
-15,950
| -2% | -$901K |
|
740
Martin Marietta Materials
MLM
$33B
| $37.1M | 0.02% |
215,747
+33,208
| +18% | +$5.9M |
|
741
GSK
GSK
$104B
| $37M | 0.02% |
773,359
+15,017
| +2% | +$740K |
|
742
Vanguard Financials ETF
VFH
$13.8B
| $37M | 0.02% |
622,532
-694,036
| -53% | -$45M |
|
743
MACOM Technology Solutions
MTSI
$22.7B
| $36.9M | 0.02% |
2,545,671
-2,640,180
| -51% | -$42.6M |
|
744
Ultragenyx Pharmaceutical
RARE
$2.64B
| $36.8M | 0.02% |
846,472
-385,801
| -31% | -$21.1M |
|
745
SAP
SAP
$241B
| $36.7M | 0.02% |
369,398
-68,099
| -16% | -$7.24M |
|
746
Cintas
CTAS
$81.1B
| $36.7M | 0.02% |
873,284
-552
| -0.1% | -$24.7K |
|
747
CNO Financial Group
CNO
$5.12B
| $36.6M | 0.02% |
2,461,500
-297,088
| -11% | -$5.42M |
|
748
ONE Gas
OGS
$4.96B
| $36.6M | 0.02% |
460,482
-7,906
| -2% | -$652K |
|
749
Teledyne Technologies
TDY
$32B
| $36.5M | 0.02% |
176,482
+1,036
| +0.6% | +$227K |
|
750
iShares S&P Small-Cap 600 Value ETF
IJS
$8.3B
| $36.3M | 0.02% |
551,462
+85,530
| +18% | +$6.35M |
|
Similar funds
Ameriprise's Q4 2018 Portfolio in Review
As of Q4 2018, Ameriprise held 3,899 positions worth $200B, down 30% from $286B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Ameriprise's Q4 2018 filing shows 170 new, 1,630 increased, 1,715 reduced and 248 closed positions. Its largest new stake was Linde: 460,065 shares worth $71.8M. The largest sale was Express Scripts Holding Company, an estimated $475M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q4 2018 buy was Linde: 460,065 shares worth $71.8M.
- Ameriprise added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q4 2018, an estimated $760M increase.
- Ameriprise's biggest Q4 2018 reduction was Pfizer, cutting an estimated $356M.
- Ameriprise fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $475M.
- Ameriprise's ten largest holdings make up 14% of its $200B portfolio in Q4 2018.
- Ameriprise opened 170 new positions and closed 248 in Q4 2018.
- Ameriprise's portfolio value fell 30% quarter-over-quarter to $200B.
Based on Ameriprise's 13F filing for Q4 2018, filed 14 Feb 2019.